LEVODOPA and COUGH

Overview

COUGH is the #1 most commonly reported adverse reaction for LEVODOPA, manufactured by Merz Pharmaceuticals, LLC. There are 2,192 FDA adverse event reports linking LEVODOPA to COUGH. This represents approximately 8.2% of all 26,727 adverse event reports for this drug.

Patients taking LEVODOPA who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

COUGH is moderately reported among LEVODOPA users, representing a notable but not dominant share of adverse events.

Other Side Effects of LEVODOPA

In addition to cough, the following adverse reactions have been reported for LEVODOPA:

• DRUG INEFFECTIVE — 1,358 reports
• PARKINSON^S DISEASE — 1,033 reports
• DYSKINESIA — 732 reports
• DEATH — 669 reports
• FALL — 667 reports
• CONDITION AGGRAVATED — 662 reports
• DEVICE ISSUE — 655 reports
• HALLUCINATION — 613 reports
• PRODUCT RESIDUE PRESENT — 541 reports
• TREMOR — 507 reports

Other Drugs Associated with COUGH

The following drugs have also been linked to cough in FDA adverse event reports:

Does LEVODOPA cause COUGH?

COUGH has been reported as an adverse event in 2,192 FDA reports for LEVODOPA. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is COUGH with LEVODOPA?

COUGH accounts for approximately 8.2% of all adverse event reports for LEVODOPA, making it one of the most commonly reported side effect.

What should I do if I experience COUGH while taking LEVODOPA?

If you experience cough while taking LEVODOPA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages